Medicare Enrolled
Dr. Edward Whitesides, M.D.
Urology Physician · Wilmington, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Whitesides from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Whitesides?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Whitesides
Dr. Edward Whitesides is an urology physician in Wilmington, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Whitesides performed 2,075 Medicare services across 1,723 unique beneficiaries.
Between the years covered by Open Payments, Dr. Whitesides received a total of $9,272 from 60 pharmaceutical and/or device companies across 486 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Whitesides is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 37% volume in NC
$9,272 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,075
Medicare services
Top 37% in NC for urology physician
1,723
Unique beneficiaries
$35
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~104 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
601 | $3 | $20 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
338 | $74 | $199 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
232 | $58 | $140 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
203 | $8 | $20 |
| PSA test (prostate cancer screening) | 185 | $18 | $100 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
93 | $7 | $75 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
73 | $19 | $113 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
67 | $30 | $100 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
44 | $153 | $432 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
40 | $10 | $30 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
38 | $19 | $73 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
31 | $25 | $130 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
27 | $62 | $119 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
18 | $122 | $1,680 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
17 | $304 | $1,007 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
15 | $88 | $275 |
| Imaging guidance for procedure, 60 minutes or less Use of imaging technology to guide a medical procedure. This service lasts 60 minutes or less. |
14 | $11 | $106 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
14 | $109 | $350 |
| Insertion of temporary bladder tube | 13 | $32 | $140 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
12 | $127 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.7% high complexity
8.9% medium
89.4% routine
Industry Payment Transparency
Open Payments through 2023 ↗$9,272
Total received (2018-2023)
Avg $1,545/year across 6 years
Top 19% in NC for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
486
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,712 (94.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$560 (6.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2023
$1,198
2022
$2,490
2021
$1,652
2020
$1,064
2019
$1,430
2018
$1,436
Payments by company (2023)
Consulting
Speaking
Meals & Travel
Research
Sumitomo Pharma America, Inc.
$230
Dendreon Pharmaceuticals LLC
$158
PFIZER INC.
$157
Janssen Biotech, Inc.
$136
ACCORD HEALTHCARE, INC.
$112
Astellas Pharma US Inc
$61
Teleflex LLC
$59
180 Medical, Inc.
$51
ABBVIE INC.
$46
Bayer Healthcare Pharmaceuticals Inc.
$43
AstraZeneca Pharmaceuticals LP
$33
Novartis Pharmaceuticals Corporation
$21
Endo Pharmaceuticals Inc.
$18
Supernus Pharmaceuticals, Inc.
$16
Axonics, Inc.
$15
ABC Home Medical Supply, Inc.
$14
PROCEPT BioRobotics Corporation
$14
Photocure Inc
$13
Top 3 companies account for 45.5% of 2023 payments
All-time payments by company (2018-2023) ›
Astellas Pharma US Inc
$1,924
Dendreon Pharmaceuticals LLC
$1,739
Janssen Biotech, Inc.
$965
PFIZER INC.
$534
Endo Pharmaceuticals Inc.
$339
Bayer HealthCare Pharmaceuticals Inc.
$288
180 Medical, Inc.
$272
Amgen Inc.
$261
Myovant Sciences Inc.
$242
Sumitomo Pharma America, Inc.
$230
UROVANT SCIENCES INC
$159
Merck Sharp & Dohme Corporation
$154
Blue Earth Diagnostics Limited
$142
Teleflex LLC
$127
AstraZeneca Pharmaceuticals LP
$126
ACCORD HEALTHCARE, INC.
$112
Antares Pharma, Inc.
$93
Ferring Pharmaceuticals Inc.
$90
Myriad Genetic Laboratories, Inc.
$89
COLOPLAST CORP
$83
Acerus Pharmaceuticals Corporation
$77
ABBVIE INC.
$76
Janssen Scientific Affairs, LLC
$72
Accord Healthcare, Inc.
$69
Janssen Products, LP
$60
Novartis Pharmaceuticals Corporation
$59
Foundation Medicine, Inc.
$58
Allergan, Inc.
$52
MEDIVATION FIELD SOLUTIONS LLC
$51
Boston Scientific Corporation
$49
Axonics, Inc.
$46
Merck Sharp & Dohme LLC
$45
Bayer Healthcare Pharmaceuticals Inc.
$43
Palette Life Sciences, Inc.
$38
Coloplast Corp
$36
Smith+Nephew, Inc.
$35
Sun Pharmaceutical Industries Inc.
$34
Augmenix, Inc.
$29
Aytu BioScience, Inc
$27
UROGEN PHARMA, INC.
$26
Zyla Life Sciences, Inc.
$25
Laborie Medical Technologies Corp.
$24
AbbVie Inc.
$21
Medtronic USA, Inc.
$21
AbbVie, Inc.
$18
Olympus America Inc.
$17
BOSTON SCIENTIFIC CORPORATION
$16
Supernus Pharmaceuticals, Inc.
$16
UroGen Pharma, Inc.
$15
Allergan Inc.
$15
Avadel Specialty Pharmaceuticals, LLC
$15
Retrophin, Inc.
$15
AMAG Pharmaceuticals, Inc.
$14
ABC Home Medical Supply, Inc.
$14
PROCEPT BioRobotics Corporation
$14
ARGON MEDICAL DEVICES, INC.
$14
Ethicon US, LLC
$13
Photocure Inc
$13
SUN PHARMACEUTICAL INDUSTRIES INC.
$12
EDAP TECHNOMED INC
$7
Top 3 companies account for 49.9% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ALTIS · AMS 700 CXR RTE KIT · AQUABEAM ROBOTIC SYSTEM · Altis · Axonics · Axonics r-SNM System · Axumin · BOTOX · BOTOX THERAPEUTIC · BRAC CDx · BRACANALYSIS CDX · BRACAnalysis CDx · CAMCEVI · CURE CATHETER · CYSVIEW · ERLEADA · Enseal · Erleada · FIRMAGON · FOUNDATIONONE · GEMTESA · GENERAL THERAPIES · GENTLECATH · GentleCath · INTERSTIM ICON · INTRAROSA · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · PLUVICTO · PROVENGE · PVC · Prolaris · Prolia · REZUM · SPRIX · STRAVIX · SpaceOAR · SpeediCath · TITAN · TRU-CORE · Titan · UROLIFT · Veozah · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (94%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
19
Per 100K population
8.2
County median income
$72,892
Nearest hospital
WILMINGTON TREATMENT CENTER
7.1 mi
7.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2023 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Whitesides is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 19% of NC peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Whitesides experienced with urinalysis, manual?
Based on Medicare claims data, Dr. Whitesides performed 601 urinalysis, manual services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Whitesides receive payments from pharmaceutical companies?
Yes. Dr. Whitesides received a total of $9,272 from 60 companies across 486 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Whitesides's costs compare to other urology physicians in Wilmington?
Dr. Whitesides's average Medicare payment per service is $35. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Whitesides) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Wilmington
Browse urology physicians in Wilmington ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NC
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NC
Which NC urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology